ACAD
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 340 / Fiscal Year End: 2016-12-31 / Stock Type: Small Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

ACADIA Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the business of development and commercialization of medicines to address unmet medical needs in central nervous system disorders.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | NVO | GILD | CELG | BIIB | SHPG | VRTX | REGN | ALXN | GRFS | INCY | NKTR | CLRB |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2016-12-25Quarter11,962k1,704k0.0-78,696k-78,696k121,243,k85.80%-657.90%-657.90%
2017-03-25Quarter15,286k2,263k0.0-87,843k-87,843k121,651,k85.20%-574.70%-574.70%
2017-06-25Quarter30,475k2,224k0.0-67,441k-67,441k122,122,k92.70%-221.30%-221.30%
2017-09-25Quarter35,578k2,135k0.0-65,248k-65,248k122,484,k94.00%-183.40%-183.40%
2017-12-25Quarter43,562k2,455k0.0-68,871k-68,871k124,133,k94.40%-158.10%-158.10%
2018-03-25Quarter48,868k2,153k0.0-54,296k-54,296k124,727,k95.60%-111.10%-111.10%
2018-06-25Quarter57,063k3,562k0.0-63,266k-63,266k124,910,k93.80%-110.90%-110.90%
2018-09-25Quarter58,305k3,839k0.0-62,138k-62,138k125,009,k93.40%-106.60%-106.60%
2018-12-25Quarter59,571k2,823k0.0-65,492k-65,492k131,683,k95.30%-109.90%-109.90%
2019-03-25Quarter62,959k2,950k0.0-85,304k-85,304k143,981,k95.30%-135.50%-135.50%
2019-06-25Quarter83,205k2,958k0.0-54,941k-54,941k144,314,k96.40%-66.00%-66.00%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2017-12-25Quarter264.17%44.07%0.00%-12.48%-12.48%2.38%10.02%-75.97%-75.97%
2018-03-25Quarter219.69%-4.86%0.00%-38.19%-38.19%2.53%12.21%-80.67%-80.67%
2018-06-25Quarter87.25%60.16%0.00%-6.19%-6.19%2.28%1.19%-49.89%-49.89%
2018-09-25Quarter63.88%79.81%0.00%-4.77%-4.77%2.06%-0.64%-41.88%-41.88%
2018-12-25Quarter36.75%14.99%0.00%-4.91%-4.91%6.08%0.95%-30.49%-30.49%
2019-03-25Quarter28.83%37.02%0.00%57.11%57.11%15.44%-0.31%21.96%21.96%
2019-06-25Quarter45.81%-16.96%0.00%-13.16%-13.16%15.53%2.77%-40.49%-40.49%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter518,411k561,153k42,742k547,897k42,585k157k12.129.078
2017-03-25Quarter457,524k503,013k45,489k489,753k45,265k224k10.058.092
2017-06-25Quarter415,140k456,315k41,175k443,745k40,913k262k10.082.092
2017-09-25Quarter377,326k413,714k36,388k401,972k36,143k245k10.370.090
2017-12-25Quarter335,285k384,506k49,221k373,477k49,030k191k6.812.131
2018-03-25Quarter304,169k351,040k46,871k340,014k46,089k782k6.489.136
2018-06-25Quarter264,720k314,960k50,240k301,096k49,214k1,026k5.269.163
2018-09-25Quarter223,440k266,456k43,016k254,116k41,807k1,209k5.194.165
2018-12-25Quarter479,079k540,202k61,123k526,106k59,565k1,558k7.838.113
2019-03-25Quarter418,356k501,105k82,749k476,406k74,983k7,766k5.056.157

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter-35.32%-31.48%15.16%-31.83%15.13%21.66%-43.84%67.95%
2018-03-25Quarter-33.52%-30.21%3.04%-30.57%1.82%249.11%-35.48%47.83%
2018-06-25Quarter-36.23%-30.98%22.02%-32.15%20.29%291.60%-47.74%77.17%
2018-09-25Quarter-40.78%-35.59%18.21%-36.78%15.67%393.47%-49.91%83.33%
2018-12-25Quarter42.89%40.49%24.18%40.87%21.49%715.71%15.06%-13.74%
2019-03-25Quarter37.54%42.75%76.55%40.11%62.69%893.09%-22.08%15.44%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note